he big issue now is: is there a distribution agreement with BP (1). Will sales be strong and not meet resistance from prescribers (2). DNDN decided to go alone and borrow 500 M to build plants. Could not get market share and huge losses. Stock from 50 to 2. ARNA could not have increased sales got 2nd tier partner.
Market Data 
Markets 
AI
